Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Lindland K, Juzeniene A(2025) Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models EJNMMI Radiopharm Chem, 10(1), 58 DOI 10.1186/s41181-025-00382-3, PubMed 40885785
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB(2025) Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy Mol Cancer Ther(in press) DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114
